ATE200734T1 - Zusammensetzung und verfahren zur verminderung des hypotensionsrisikos - Google Patents

Zusammensetzung und verfahren zur verminderung des hypotensionsrisikos

Info

Publication number: ATE200734T1
Authority: AT; Austria
Prior art keywords: composition; risk; hypotension; patient; reducing
Prior art date: 1992-11-05

Application number

AT93117796T

Other languages

English (en)

Inventor

David A Mark

Gary Pace

Original Assignee

Nestle Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-11-05

Filing date

1993-11-03

Publication date

2001-05-15

1993-11-03 Application filed by Nestle Sa filed Critical Nestle Sa

2001-05-15 Application granted granted Critical

2001-05-15 Publication of ATE200734T1 publication Critical patent/ATE200734T1/de

Links

208000001953 Hypotension Diseases 0.000 title abstract 3
230000036543 hypotension Effects 0.000 title abstract 3
239000004475 Arginine Substances 0.000 abstract 2
MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 abstract 2
ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 abstract 2
230000015572 biosynthetic process Effects 0.000 abstract 1
235000016709 nutrition Nutrition 0.000 abstract 1
238000002560 therapeutic procedure Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
- A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Zoology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Gastroenterology & Hepatology (AREA)
Marine Sciences & Fisheries (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Heart & Thoracic Surgery (AREA)
Diabetes (AREA)
Obesity (AREA)
Cardiology (AREA)
Hematology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines Containing Plant Substances (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
External Artificial Organs (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AT93117796T 1992-11-05 1993-11-03 Zusammensetzung und verfahren zur verminderung des hypotensionsrisikos ATE200734T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US07/971,949 US5356873A (en)	1992-11-05	1992-11-05	Method for providing nutritional requirements to patients having a chronic inflammation reaction

Publications (1)

Publication Number	Publication Date
ATE200734T1 true ATE200734T1 (de)	2001-05-15

Family

ID=25518983

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT93117796T ATE200734T1 (de)	1992-11-05	1993-11-03	Zusammensetzung und verfahren zur verminderung des hypotensionsrisikos

Country Status (11)

Country	Link
US (1)	US5356873A (de)
EP (1)	EP0612522B1 (de)
JP (1)	JPH0797332A (de)
AT (1)	ATE200734T1 (de)
AU (1)	AU5040593A (de)
CA (1)	CA2109392A1 (de)
DE (1)	DE69330177T2 (de)
DK (1)	DK0612522T3 (de)
ES (1)	ES2157208T3 (de)
GR (1)	GR3036272T3 (de)
PT (1)	PT612522E (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5585402A (en) *	1992-12-23	1996-12-17	Glaxo Wellcome Inc.	Nitric oxide synthase inhibitors
US5378722A (en) *	1993-12-03	1995-01-03	Clintec Nutrition Co.	Nutritional compositions for management of nitrogen metabolism
US5576287A (en) *	1994-04-29	1996-11-19	Wake Forest University	Method for treating acute renal disease and failure
AU781734B2 (en) *	1999-04-29	2005-06-09	Hans Medical AB	Use of heparin-binding antagonists in the inhibition of bradykinin release
US6833350B2 (en)	2000-02-04	2004-12-21	Nestec S.A.	Method for maintaining or improving the synthesis of mucins
WO2006009437A2 (en) *	2004-07-19	2006-01-26	N.V. Nutricia	Use of aspartate for regulating glucose levels in blood
US20090291877A1 (en) *	2006-04-04	2009-11-26	Nicolaas Emile Deutz	Treatments using citrulline
JOP20190146A1 (ar)	2016-12-19	2019-06-18	Axcella Health Inc	تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
EP3668499A1 (de)	2017-08-14	2020-06-24	Axcella Health Inc.	Aminosäurezusammensetzungen zur behandlung von lebererkrankungen
WO2019246225A1 (en)	2018-06-20	2019-12-26	Axcella Health Inc.	Compositions and methods for the treatment of fat infiltration in muscle

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4752618A (en) *	1984-07-12	1988-06-21	New England Deaconess Hospital	Method of minimizing efects of infection through diet
US4647453A (en) *	1984-10-18	1987-03-03	Peritain, Ltd.	Treatment for tissue degenerative inflammatory disease
US4780475A (en) *	1986-02-03	1988-10-25	Cerra Frank B	Preparation for the prevention of catabolism
US5055446A (en) *	1988-10-21	1991-10-08	University Of Cincinnati	Method to improve survival of patients during sepsis by diet composition
US5158883A (en) *	1989-09-13	1992-10-27	Cornell Research Foundation, Inc.	Method of using aminoarginine to block nitric oxide formation in vitro
US5028627A (en) *	1989-09-13	1991-07-02	Cornell Research Foundation, Inc.	Method of using arginine derivatives to inhibit systemic hypotension associated with nitric oxide production or endothelial derived relaxing factor
EP0441119A3 (en) *	1990-01-09	1992-10-14	Richard D. Levere	The use of l-arginine in the treatment of hypertension and other vascular disorders
CA2036770C (en) *	1990-02-26	2003-09-09	Jeffrey P. Whitten	Inhibitors of nitric oxide biosynthesis
ATE174794T1 (de) *	1991-09-27	1999-01-15	Univ Texas	Parenteral anzuwendende aminosäuren enthaltende zubereitungen zur bekämpfung von hypotension und verwandten pathologien

1992
- 1992-11-05 US US07/971,949 patent/US5356873A/en not_active Expired - Lifetime
1993
- 1993-10-27 CA CA002109392A patent/CA2109392A1/en not_active Abandoned
- 1993-11-03 AU AU50405/93A patent/AU5040593A/en not_active Abandoned
- 1993-11-03 EP EP93117796A patent/EP0612522B1/de not_active Expired - Lifetime
- 1993-11-03 PT PT93117796T patent/PT612522E/pt unknown
- 1993-11-03 AT AT93117796T patent/ATE200734T1/de not_active IP Right Cessation
- 1993-11-03 DK DK93117796T patent/DK0612522T3/da active
- 1993-11-03 ES ES93117796T patent/ES2157208T3/es not_active Expired - Lifetime
- 1993-11-03 DE DE69330177T patent/DE69330177T2/de not_active Expired - Fee Related
- 1993-11-05 JP JP5277044A patent/JPH0797332A/ja active Pending
2001
- 2001-07-24 GR GR20010401121T patent/GR3036272T3/el not_active IP Right Cessation

Also Published As

Publication number	Publication date
EP0612522B1 (de)	2001-04-25
DK0612522T3 (da)	2001-08-13
CA2109392A1 (en)	1994-05-06
US5356873A (en)	1994-10-18
ES2157208T3 (es)	2001-08-16
JPH0797332A (ja)	1995-04-11
GR3036272T3 (en)	2001-10-31
DE69330177T2 (de)	2001-09-06
EP0612522A1 (de)	1994-08-31
PT612522E (pt)	2001-08-30
DE69330177D1 (de)	2001-05-31
AU5040593A (en)	1994-05-19

Legal Events

Date	Code	Title	Description
2001-07-15	UEP	Publication of translation of european patent specification
2006-08-15	REN	Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
EP0222483A3 (en)	1989-08-16	Use of gamma-linolenic acid and related compounds in the treatment of endometriosis
DE69620291D1 (de)	2002-05-08	Nahrungszusammensetzungen in verschiedenen Formen
EP1201241B8 (de)	2010-10-27	Zusammensetzungen enthaltend Capsaicin oder Capsaicin Analoge und ein Anästhetikum
AU5763094A (en)	1994-09-15	Composition and method for treating patients with hepatic disease
ATE184792T1 (de)	1999-10-15	2-bromomelatonin zur behandlung von schlafstörungen
EP0690722A4 (de)	1997-08-06	Zusammensetzung und methode zur reduktion der toxizität von biologisch-aktiven faktoren
TW336171B (en)	1998-07-11	Pharmaceutical composition for use in the treatment of vulvar dystrophy and/or vaginal dryness
DE69330177D1 (de)	2001-05-31	Zusammensetzung und Verfahren zur Verminderung des Hypotensionsrisikos
DE3680271D1 (de)	1991-08-22	Thrombolytische zusammensetzung und verfahren zu deren herstellung.
EP0506658A4 (en)	1993-03-03	Compositions and method for treating painful, inflammatory or allergic disorders
EP0934748A3 (de)	2001-01-31	Von Willenbrand Faktor (vWF) enthaltende Zubereitung, verfahren zür Herstellung von vWF enthaltenden Zubereitungen und deren Verwendung
ATE268587T1 (de)	2004-06-15	Gebrauch von silicongummi zur stabilisierung von ascorbinsaüre und vorbereitungen die diese zusammensetzungen enthalten
EP0502313A3 (en)	1993-05-12	Method for insuring adequate intracellular glutathione in tissue
EP0158880A3 (en)	1986-01-08	Liposomes with inhalable allergens for treatment of allergies, method for their preparation and pharmaceutical compositions containing them
ATE171071T1 (de)	1998-10-15	Verfahren und zusammensetzungen zur verminderung von blutverlust
DE69433923D1 (de)	2004-09-02	Salbe enthaltend mometason-furoat und salicylsäure zur topischen behandlung von psoriasis
DE69002743D1 (de)	1993-09-16	Verfahren zur verbesserung der ventilation waehrend des schlafes und behandlung von ventilationsabnormalitaeten, die mit dem schlaf verbunden sind.
TW232014B (de)	1994-10-11
TW217382B (de)	1993-12-11
ATE302611T1 (de)	2005-09-15	Humanes wachstumshormon als hilfe gegen unterkühlung